PT-141 Synonyms / Designations: PT-141, Bremelanotide, Melanotan II analogue CAS Number: 189691-06-3 Molecular Formula: C50H68N14O10 Molecular Weight: ~1025.18 g/mol Peptide Length: 7 amino acids (cyclic peptide) Peptide Type: Synthetic melanocortin receptor agonist Purity: 99 % (HPLC, typical) Appearance: White to off-white lyophilised powder Pack Size: 10 mg (typical) Storage : Desiccated, protected from light, stored at 20 C or below Solubility: Soluble in water and buffered aqueous solutions Description & Mechanism PT-141 is a synthetic cyclic heptapeptide derived from melanocortin peptides and developed for experimental investigation of melanocortin receptormediated signalling pathways

For 503A pharmacies, FDA reiterated a limited enforcement policy from its 2018 guidance, Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act: the agency does not intend to take action where a compounder fills four or fewer prescriptions per calendar month of a drug that is essentially a copy of a commercially available drug
Essential baseline evaluations include thyroid function, amylase and lipase levels, renal function, and imaging if history of thyroid disease exists
D., Seal, D., & Emanuel, F
There are no documented interactions between GHK-Cu and GLP-1 receptor agonists like Semaglutide or triple-action compounds like Retatrutide
Antioxidants & Redox Signaling, 8 (56), 753762